Document Detail


Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
MedLine Citation:
PMID:  17720068     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To compare the incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated postoperatively with topical prednisolone and those treated with topical prednisolone and nepafenac 0.1% suspension (Nevanac).
SETTING: Edward S. Harkness Eye Institute of Columbia University, New York, New York, USA.
METHODS: This retrospective chart review was of consecutive patients who had phacoemulsification at a single institute and were given topical prednisolone alone or topical prednisolone and nepafenac to prevent cystoid macular edema. Data collection included preexisting ocular and systemic diseases, concurrent use of ocular and systemic medications, surgical technique, intraoperative and postoperative complications, follow-up visual and ocular assessments, and postoperative optical coherence tomography (OCT) assessment for macular edema.
RESULTS: Postoperatively, 240 patients were treated with prednisolone and 210 patients, with prednisolone-nepafenac. Preoperatively, the 2 groups were demographically and clinically comparable in sex distribution (P = .8400), history of diabetes (P = .7267), hypertension or cardiac disease (P = .8690), and concurrent use of oral nonsteroidal anti-inflammatory drugs (P = .7303). Iris manipulation was done in 16 patients in the prednisolone-alone group and 10 patients in the prednisolone-nepafenac group (P = .3876). Capsule staining was done in 5 patients and 4 patients, respectively. All patients were followed for at least 1 month postoperatively. Visually significant pseudophakic macular edema was documented by OCT in 5 patients treated with prednisolone alone and in no patients treated with prednisolone and nepafenac (P = .0354). No significant intraoperative or postoperative complications were reported.
CONCLUSION: Patients treated with topical prednisolone alone had a significantly higher incidence of visually significant pseudophakic macular edema after uneventful cataract surgery than those treated with topical prednisolone and nepafenac.
Authors:
Eric J Wolf; Alexandra Braunstein; Carolyn Shih; Richard E Braunstein
Related Documents :
15881258 - Assessment of macular function by multifocal electroretinogram in diabetic macular edem...
23460018 - Incidence of sinusoidal obstruction syndrome following mylotarg (gemtuzumab ozogamicin)...
11986098 - Intravitreal triamcinolone for refractory diabetic macular edema.
17333238 - Intravitreal bevacizumab (avastin) in combination with verteporfin photodynamic therapy...
15881258 - Assessment of macular function by multifocal electroretinogram in diabetic macular edem...
21872978 - Coiled versus straight peritoneal dialysis catheters: a randomized controlled trial and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cataract and refractive surgery     Volume:  33     ISSN:  0886-3350     ISO Abbreviation:  J Cataract Refract Surg     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-27     Completed Date:  2007-10-16     Revised Date:  2013-08-26    
Medline Journal Info:
Nlm Unique ID:  8604171     Medline TA:  J Cataract Refract Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1546-9     Citation Subset:  IM    
Affiliation:
Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons, Department of Ophthalmology, 635 West 165th Street, New York, New York 10032, USA. ericwolfmd@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Benzeneacetamides / therapeutic use*
Drug Therapy, Combination
Female
Glucocorticoids / therapeutic use
Humans
Incidence
Macular Edema / etiology,  prevention & control*
Male
Middle Aged
Phacoemulsification*
Phenylacetates / therapeutic use*
Postoperative Complications / prevention & control*
Prednisolone / therapeutic use
Pseudophakia / etiology*
Retrospective Studies
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Benzeneacetamides; 0/Glucocorticoids; 0/Phenylacetates; 0J9L7J6V8C/nepafenac; 50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfen...
Next Document:  Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatme...